Nyrada Inc Trading Halt
Key points
- Nyrada Inc has requested a trading halt on its ASX securities.
- The halt is pending an announcement regarding a pre-clinical oncology study.
- The securities will remain halted until the announcement or until 21 May 2026.
- No further information is necessary to inform the market about the trading halt.
Full summary
Nyrada Inc. (ASX: NYR) has requested a trading halt on its securities on the Australian Securities Exchange (ASX) pending a material announcement in relation to a pre-clinical oncology study, as noted in the Company's Quarterly Activities Report. The halt is necessary to manage continuous disclosure obligations and will remain in place until the announcement is made or until the commencement of normal trading on Thursday, 21 May 2026.
Outlook
The trading halt is requested pending an announcement regarding the pre-clinical oncology study, which is expected to be released to the market soon.
Summary generated by a large language model. Please interpret with care.